![Christoffer Rosenblad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/05/2026
Christoffer Rosenblad is currently Chief Executive Officer at Xvivo Perfusion AB since 2022, Director at Bentley Endovascular Group AB, and Independent Director at Sedana Medical AB since 2020.
Formerly, Mr. Rosenblad worked as Controller at Ciba Vision Nordic AB. Education includes a graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
XVIVO PERFUSION AB 0,17 % | 29/07/2025 | 53.523 ( 0,17 % ) | 2 M $ | 31/05/2026 |
SEDANA MEDICAL AB 0,02 % | 31/12/2024 | 20.000 ( 0,02 % ) | 20 383 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XVIVO PERFUSION AB | Director Ejecutivo | 27/09/2022 |
| SEDANA MEDICAL AB | Director/Miembro de la Junta | 19/05/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Ciba Vision Nordic AB | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Handelshögskolan i Göteborg
 Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba Vision Nordic AB | |
Xvivo Perfusion AB
 Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
Sedana Medical AB
 Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
